$VRNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Verona Pharma plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Verona Pharma plc. Get notifications about new insider transactions in Verona Pharma plc for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | VRNA | Verona Pharma plc | Ullman Anders | Director | Sell | S | 0.84 | 12,056 | 10,123 | 334,856 | 346.9 K to 334.9 K (-3.48 %) |
May 05 2021 | VRNA | Verona Pharma plc | Deschamps Lisa | Director | Sell | S | 0.84 | 10,680 | 8,968 | 105,320 | 116 K to 105.3 K (-9.21 %) |
May 05 2021 | VRNA | Verona Pharma plc | Cunningham Kenneth | Director | Sell | S | 0.84 | 13,112 | 11,010 | 66,584 | 79.7 K to 66.6 K (-16.45 %) |
May 05 2021 | VRNA | Verona Pharma plc | Sinha Vikas | Director | Sell | S | 0.84 | 10,016 | 8,410 | 74,440 | 84.5 K to 74.4 K (-11.86 %) |
May 05 2021 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | Sell | S | 0.84 | 11,184 | 9,391 | 684,643 | 695.8 K to 684.6 K (-1.61 %) |
May 05 2021 | VRNA | Verona Pharma plc | Edwards Martin | Director | Sell | S | 0.84 | 12,024 | 10,097 | 111,064 | 123.1 K to 111.1 K (-9.77 %) |
May 05 2021 | VRNA | Verona Pharma plc | SHAH MAHENDRA | Director | Sell | S | 0.84 | 10,680 | 8,968 | 73,080 | 83.8 K to 73.1 K (-12.75 %) |
May 05 2021 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | Sell | S | 0.81 | 52,056 | 41,926 | 17,859,160 | 17.9 M to 17.9 M (-0.29 %) |
May 05 2021 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | Payment of Exercise | F | 0.89 | 2,139,632 | 1,898,923 | 17,911,216 | 20.1 M to 17.9 M (-10.67 %) |
Mar 03 2021 | VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Off ... | Sell | S | 1.14 | 26,728 | 30,571 | 19,054,504 | 19.1 M to 19.1 M (-0.14 %) |
Mar 03 2021 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | Sell | S | 1.14 | 43,392 | 49,627 | 20,050,848 | 20.1 M to 20.1 M (-0.22 %) |
Mar 03 2021 | VRNA | Verona Pharma plc | Deschamps Lisa | Director | Grant | A | 0.00 | 116,000 | 0 | 116,000 | 0 to 116 K |
Feb 03 2021 | VRNA | Verona Pharma plc | Ullman Anders | Director | Sell | S | 0.99 | 10,800 | 10,733 | 346,912 | 357.7 K to 346.9 K (-3.02 %) |
Feb 03 2021 | VRNA | Verona Pharma plc | Sinha Vikas | Director | Sell | S | 0.99 | 10,224 | 10,161 | 84,456 | 94.7 K to 84.5 K (-10.80 %) |
Feb 03 2021 | VRNA | Verona Pharma plc | SHAH MAHENDRA | Director | Sell | S | 0.99 | 10,800 | 10,733 | 83,760 | 94.6 K to 83.8 K (-11.42 %) |
Feb 03 2021 | VRNA | Verona Pharma plc | Edwards Martin | Director | Sell | S | 0.99 | 13,688 | 13,603 | 123,088 | 136.8 K to 123.1 K (-10.01 %) |
Feb 03 2021 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | Sell | S | 0.99 | 11,912 | 11,838 | 695,827 | 707.7 K to 695.8 K (-1.68 %) |
Feb 03 2021 | VRNA | Verona Pharma plc | Cunningham Kenneth | Director | Sell | S | 0.99 | 13,104 | 13,023 | 79,696 | 92.8 K to 79.7 K (-14.12 %) |
Feb 01 2021 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | Grant | A | 0.00 | 529,104 | 0 | 20,094,240 | 19.6 M to 20.1 M (+2.70 %) |
Feb 01 2021 | VRNA | Verona Pharma plc | Hahn Mark W | Chief Financial Off ... | Grant | A | 0.00 | 105,824 | 0 | 19,081,232 | 19 M to 19.1 M (+0.56 %) |
Page: 1